CARBIOTIX AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0566 SEK | -8.12% |
|
-12.92% | -85.85% |
| 04-25 | Carbiotix AB Signs First NutraCycle Joint Development Agreement with Leading Nordic Plant-Based Food & Beverage Producer | CI |
| 04-04 | Carbiotix Kicks Off Pilot Study for NutraCycle Service | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Carbiotix AB (publ) is a Sweden-based company with operations focused on intestinal health. The Company is engaged in microbiome healthcare through a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics, alongside a range of gut health testing services. The Companyâs business is conducted through four business legs: development of the prebiotic fiber Carbiotix AXOS, drug development linked to various metabolic and chronic diseases. sales of consumer and clinical tests for intestinal health and sales of medical food containing AXOS.
Calendar
05/08/2024
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -85.85% | 941K | |
| +29.84% | 48.16B | |
| +0.03% | 41.73B | |
| +43.29% | 41.03B | |
| -5.31% | 28.77B | |
| +10.82% | 25.59B | |
| -22.02% | 18.96B | |
| +9.43% | 12.92B | |
| +28.51% | 12.03B | |
| -2.69% | 11.77B |
- Stock Market
- Equities
- CRBX Stock
- News Carbiotix AB
- Carbiotix Kicks Off Pilot Study for NutraCycle Service
